Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention

Abstract

Acute ST segment elevation myocardial infarction (STEMI) is one of the causes of death and disability in patients with cardiovascular diseases. This study aimed to investigate the prognostic factors of in-hospital and long-term survival in patients with acute STEMI undergoing percutaneous coronary intervention (PCI). Patients with STEMI undergoing PCI were divided into the death group (n = 54) and the survival group (n = 306) based on the outcomes during hospitalization. The routine blood and biochemistry tests, Killip classes and global registry of acute coronary events (GRACE) risk score were detected. The 1-, 2-and 3-year survival rates after PCI was observed through a 3-year follow-up. The survival factors, survival rates and multivariate analyses were conducted using Logistic regression analysis, Kaplan-Meier survival analysis and Cox proportional hazards regression. The incidence of cardiogenic shock and anterior wall MI (AWMI), the serum levels of γ-glutamyl endopeptidase (γ-GGT) and creatine kinase isoenzyme MB (CK-MB), Killip classes and GRACE risk score were higher in the death group, compared with the survival group. AWMI, cardiogenic shock, high serum levels of γ-GGT and CK-MB, Killip class III-IV and high GRACE risk scores were associated with in-hospital mortality. AWMI, cardiogenic shock, Killip class III-IV and high GRACE risk scores were correlated with a poor long-term survival. Our findings have demonstrated that AWMI, cardiogenic shock, high serum levels of γ-GGT and CK-MB, Killip class III-IV, and high GRACE risk scores are risk factors for in-hospital and long-term prognosis of acute STEMI patients.

MiR-134-5p Regulates Myocardial Apoptosis and Angiogenesis by Directly Targeting KDM2A After Myocardial Infarction

“…M yocardial infarction (MI) is the main cause of high disability and mortality in patients with cardiovascular diseases worldwide. 1,2) The mechanism of myocardial repair after MI is very complicated. At present, MI treatment can only relieve the symptoms but cannot solve the problem of myocardial cell loss from the root.…”

Comorbidity in acute heart failure complicating myocardial infarction

“…Обсуждаемые в данной статье коморбидность [12] и ОСН [13] имеют доказанный негативный про-гностический эффект. Нам же представилось актуальным проанализировать эффективность ЧКВ у пациентов в различных группах, а именно в зависимости от наличия или отсутствия ОСН и коморбидности.…”

Levosimendan Efficacy in Patients with Myocardial Infarction and Chronic Cerebral Ischemia

“…Из инструкции к препарату следует, что основными побочными эффектами применения ЛС являются гипотония, ЖНР и гипокалиемия. Все эти состояния потенциально способны ухудшить прогноз при остром ИМ, особенно при низкой ФВ ЛЖ и проблемах с церебральным кровотоком в условиях ХИГМ [4][5][6].…”

“…Пациенты со снижением ФВ ЛЖ менее 40%, особенно при необходимости инотропной поддержки, составляют группу наиболее высокого риска плохого исхода при ИМ [4,5]. Известно, что 3-летняя выживаемость больных, перенесших ИМ, осложненный левожелудочковой СН, составляет менее 80% [6].…”